UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 78 filers reported holding UROGEN PHARMA LTD in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,470 | +334.6% | 16,379 | +221.0% | 0.00% | – |
| Q2 2023 | $52,806 | +3129.7% | 5,102 | +2782.5% | 0.00% | – |
| Q1 2023 | $1,635 | -85.6% | 177 | -86.2% | 0.00% | – |
| Q4 2022 | $11,362 | -99.9% | 1,281 | -3.8% | 0.00% | – |
| Q3 2022 | $11,074,000 | -82.2% | 1,331 | -82.4% | 0.00% | – |
| Q2 2022 | $62,080,000 | +319.5% | 7,580 | +346.1% | 0.00% | – |
| Q1 2022 | $14,798,000 | -65.4% | 1,699 | -62.2% | 0.00% | – |
| Q4 2021 | $42,728,000 | -28.6% | 4,493 | +26.2% | 0.00% | – |
| Q3 2021 | $59,862,000 | +406.5% | 3,559 | +359.8% | 0.00% | – |
| Q2 2021 | $11,819,000 | -86.3% | 774 | -82.6% | 0.00% | – |
| Q1 2021 | $86,472,000 | +26.9% | 4,439 | +17.4% | 0.00% | – |
| Q4 2020 | $68,152,000 | -23.0% | 3,782 | -17.6% | 0.00% | – |
| Q3 2020 | $88,503,000 | +217.6% | 4,588 | +330.0% | 0.00% | – |
| Q2 2020 | $27,870,000 | -74.4% | 1,067 | -82.5% | 0.00% | – |
| Q1 2020 | $108,788,000 | +30.8% | 6,098 | +144.6% | 0.00% | – |
| Q4 2019 | $83,191,000 | +3.9% | 2,493 | -25.8% | 0.00% | – |
| Q3 2019 | $80,045,000 | – | 3,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,111,050 | $9,099,000 | 4.23% |
| GREAT POINT PARTNERS LLC | 873,424 | $7,153,000 | 1.72% |
| Wildcat Capital Management, LLC | 533,139 | $4,366,000 | 1.45% |
| Opaleye Management Inc. | 238,670 | $1,955,000 | 0.88% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,949,489 | $24,156,000 | 0.44% |
| Annandale Capital, LLC | 84,331 | $691,000 | 0.27% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $206,000 | 0.18% |
| RTW INVESTMENTS, LP | 857,464 | $7,023,000 | 0.18% |
| Harel Insurance Investments & Financial Services Ltd. | 1,025,611 | $8,400,000 | 0.18% |
| BENDER ROBERT & ASSOCIATES | 41,131 | $337,000 | 0.13% |